Even as drugmakers mounted an unprecedented response to Covid-19 last year, they continued to ignore other viruses that mostly affect poorer countries, a report found.
Even as drugmakers mounted an unprecedented response to Covid-19 last year, they continued to ignore other viruses that mostly affect poorer countries, a report found.